LDOC1 depletion enhanced the activation of EGFR, HER2, HER3, and AXL, and LDOC1 downregulation was strongly correlated with poor overall survival in patients with EGFRM advanced NSCLC who received gefitinib. The gene discussed is ERBB3; the disease is non-small cell lung carcinoma.